Breast Cancer

Article	Citations
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	110
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	91
Immune checkpoint inhibition in breast cancer: targeting PD-1/PD-L1 pathway for therapeutic advances	58
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	43
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer	42
Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma	42
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	35
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy	29
Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial	26
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	23
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study	22
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer	21
Development of a deep learning-based automated diagnostic system (DLADS) for classifying mammographic lesions — a first large-scale multi-institutional clinical trial in Japan	21
Factors associated with post acute care utilization after mastectomy for breast cancer patients	21
Emerging roles of KIR2DL4 in cancer immunotherapy	19
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	18
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	17
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	17
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study	17
The role of C1orf50 in breast cancer progression and prognosis	16
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan	16
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	16
Relevance of the MHC region for breast cancer susceptibility in Asians	15
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	15
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	15

Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	15
Glutaminase (GLS1) gene expression in primary breast cancer	14
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer	13
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	13
Impact of margin status on ipsilateral breast tumor recurrence after breast-conserving treatment for patients with breast cancer who received neoadjuvant chemotherapy: a retrospective multi-institutio	13
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	13
SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	13
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a	13
Prospective randomized-controlled trial: efficacy of 37 °C-preheated thermoplastic elastomer (TPE) bolus in postoperative radiotherapy for breast cancer patients	13
Safety of radiotherapy in patients undergoing breast reconstruction based on patient-reported outcomes: a multicenter collaborative study	13
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	13
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	13
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan	13
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	12
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer	12
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer	12
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	12
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1	12
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy	12
CT findings of lung injury during breast cancer treatment	12
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2− advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis	12
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	12
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	12
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review	11
Breast cancer screening guidelines: discrepancies raise concerns about validity	11
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	11
Chemotherapy and cognition: a promising start, but mechanistic clarity still needed	10
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein	10
Association between preoperative grip strength and postoperative upper extremity impairments in patients with breast cancer: a retrospective cohort study	10
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis	10
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study	10
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	10
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status	10
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol	10
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer	10
Impact of artificial intelligence in breast cancer screening with mammography	10
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	9
Color differences of skin paddles using the free flap for autologous breast reconstruction in Asian patients	9
Breast reconstruction-related complications from postmastectomy radiation therapy in stage II–III breast cancer: sub-analysis of a multi-institutional observational study (Reborn-03)	9
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	9
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models	9
Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions	9
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen r	9
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	9
Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer	9
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells	9
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes	9
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast	9
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	9
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	9

Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)	9
The impact of specialist palliative care on healthcare utilization among patients with breast cancer: a nationwide register-based cohort study	9
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	9
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes	9
Performance analysis of screening mammography in Asian women under 40 years	8
Patient satisfaction on prescription refill systems for breast cancer patients in Japan using a digital self-administered survey	8
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results	8
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow	8
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	8
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity	8
Correction: The therapeutic potential of high-intensity interval training in a breast cancer model: focus on the Hippo signaling pathway	8
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	8
Impact of radiation therapy on breast satisfaction and health-related quality of life after breast reconstruction: a multicenter cross-sectional controlled study (Reborn study-02)	8
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	8
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort study	8
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	8
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	8
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	8
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	8
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	7
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties	7
Management of nausea and vomiting induced by antibody–drug conjugates	7
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	7
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	7
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	7
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	7
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	7
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	7
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	7
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	7
Timing of postmastectomy radiation therapy in two-stage expander/implant-based breast reconstruction: a systematic review and meta-analysis for the 2022 Japanese breast cancer society clinical practic	7
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	7
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	7
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome	7
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	7
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women	7
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	7
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	7
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	7
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients	6
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor reg	6
Impact of community-based exercise on fatigue in early breast cancer survivors: identifying potential determinants of change	6
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	6
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	6
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	6
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	6
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	6
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	6
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study	6
Characterization of gut microbiota dysbiosis in breast cancer patients	6
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	6
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	6
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	6
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	6
Effects of CBT-based interventions on health outcomes in breast cancer patients: a systematic review and Meta-analysis	6
Comparative study of the usefulness of adjunctive tomosynthesis in breast cancer screening by mammography and ultrasound in Japan	6
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses	6
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis	6
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	6
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	6
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	6
Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery	5
Breast cancer screening rates and influencing factors among LGBTQ groups in Japan	5
Interstitial lung disorders following postoperative radiotherapy with concurrent or sequential hormonal therapy for breast cancer: a nationwide database study in Japan	5
Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis	5
Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial	5
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies	5
Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study	5
Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price	5
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database	5
Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer	5
Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study	5
Major anatomic variations of the lateral upper arm lymphatic pathway in a healthy female population	5
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community	5
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan	5
Cost-effectiveness of clinical breast examination screening programme among HER2-positive breast cancer patients: a modelling study	5
Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients	5
Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?	5
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer	5
Prospective study of once-daily accelerated partial breast irradiation using 3-dimensional conformal external beam radiotherapy for Japanese women: 12-year outcomes, toxicity, and cosmesis	5

BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion	5
KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog signaling pathway	5
Acknowledgments to reviewers 2023	5
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer	5
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole	5
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy	5
Predictive and prognostic significance of BRCAness in HER2-negative breast cancer	5
Neurospora crassa is a potential source of anti-cancer agents against breast cancer	4
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer	4
The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®	4
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer	4
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer	4
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observ	4
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer	4
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images	4
Endometrial cancer after breast cancer: caution in interpretation of risk estimates	4
Acknowledgments to reviewers 2022	4
Adjuvant radiotherapy and survival in patients with malignant phyllode tumors: a population-based retrospective study	4
C-type lectin-like domain family 2 (CLEC2D) promotes proliferation and migration of breast cancer and serves as a poor prognostic factor	4
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema	4
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients	4
Treatment and prognosis of patients with hormone receptor-low positive (1%–10%) breast cancer: a retrospective propensity score-matched analysis	4
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer	4
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a mu	4
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female	4
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case–control study of abemaciclib-induced interstitial lung disease (NOSIDE)	4
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study	4
miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway	4
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study	4
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world	4
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer	4
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study	4
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database	4
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry	4
Not all patients with premenopausal breast cancer will experience the negative effects of tamoxifen treatment on their bone mineral density	3
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective stu	3
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)	3
Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer	3
Antipsychotic therapy and breast cancer risk: a comprehensive systematic review and meta-analysis	3
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype	3
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance	3
Long-term outcomes of adjuvant radiation in elderly Asians with early stage IIA breast cancer after breast-conserving surgery: a population-based study	3
Macroscopic morphology of breast carcinoma: associations with biological subtypes and pathological features	3
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor–	3
French national survey on breast cancer care: caregiver and patient views	3
Wrapping up the evidence: bandaging in breast cancer-related lymphedema—a systematic review and meta-analysis	3
Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study	3
Identifying subgroups of ypN1 breast cancer patients who may exempt from axillary lymph node dissection after neoadjuvant chemotherapy: insights from a large cohort study	3
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 mo	3
Impact of modified dexamethasone administration sequence on infusion reaction incidence in HER2-positive breast cancer: a randomized multicenter trial	3
Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study	3
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies	3
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1	3
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy	3
Dietary intake of branched-chain amino acids in relation to the risk of breast cancer	3
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	3
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry	3
Key issues in surveillance of secondary breast cancer	3
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy	3
Development and validation of a predictive risk tool for VTE in women with breast cancer under chemotherapy: a cohort study in China	3
A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer	3
Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer	3
Reply to the Letter to the editor “Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?”	3
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry	3
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy	3
Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial	3
Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)	3
Association of adiponectin gene polymorphism with adipokine and lipid profile in breast cancer patients from Kano, Nigeria	3
"Safety and efficacy of early drain removal in breast reconstruction: a retrospective cohort study"	3
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer	3
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro	3
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer	2
Conservative axillary surgery is emerging in the surgical management of breast cancer	2
Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer	2
Improving response evaluation and treatment adaptation in hormone receptor-positive/human epidermal growth factor receptor 2-positive breast cancer	2
Pathological homogeneity and utility in the genetic diagnosis of paired mirror samples from breast cancer 10G-vacuum-assisted biopsies using a novel longitudinal dividing device	2
Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants	2
Targeting focal adhesion kinase inhibits cell migration and non-angiogenic vascularization in malignant breast cancer	2
Impact of breast density on the efficacy of radiofrequency ablation in early-stage breast cancer	2
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?	2
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors	2
Phytochemical-conjugated bio-safe gold nanoparticles in breast cancer: a comprehensive update	2
Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta‑analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition	2
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational study	2
Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis	2
Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives	2
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort	2
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre	2
Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study	2
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction	2
Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer: a prospective follow-up study	2
Antibiotic prophylaxis in breast surgery: a meta-analysis to identify the optimal strategy to reduce infection rates in breast surgery	2
Association between mammographic breast composition and breast cancer risk among Japanese women: a retrospective cohort study	2
Overall survival of patients with second primary breast cancer associated with molecular subtype and epidemiological profile at a cancer center	2
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry	2